Table 3.
Vertigo Integrated Therapy results in patients with vestibulopathies, excluding Ménière's disease.
| VIT Group | Asymptomatic | Improved | Unaltered | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60 days | 120 days | 60 days | 120 days | 60 days | 120 days | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |
| Betahistine | 14 | 10.7 | 71 | 54.2 | 91 | 69.5 | 49 | 37.4 | 26 | 19.8 | 11 | 8.4 |
| Cinnarizine | 10 | 7.0 | 48 | 33.8 | 92 | 64.8 | 69 | 48.6 | 40 | 28.2 | 25 | 17.6 |
| Clonazepam | 11 | 7.7 | 48 | 33.6 | 97 | 67.8 | 75 | 52.4 | 35 | 24.5 | 20 | 14.0 |
| Flunarizine | 8 | 5.8 | 49 | 35.5 | 80 | 58.0 | 70 | 50.7 | 50 | 36.2 | 19 | 13.8 |
| EGb 761 | 6 | 4.4 | 40 | 29.6 | 74 | 54.8 | 70 | 51.9 | 55 | 40.7 | 25 | 18.5 |
| No medication | 2 | 1.6 | 17 | 13.3 | 63 | 49.2 | 49 | 38.3 | 63 | 49.2 | 62 | 48.3 |